<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://2medical.news/2026/08/15/encapsulated-faecal-microbiota-transfer-to-target-immune-activation-in-patients-with-cirrhosis-and-ascites-transimmune-protocol-for-a-randomised-double-blind-phase-iia-placebo-controlled-trial/</loc><news:news><news:publication><news:name>2 Medical News</news:name><news:language>en-gb</news:language></news:publication><news:publication_date>2026-08-15T07:00:16+00:00</news:publication_date><news:title>Encapsulated faecal microbiota transfer to target immune activation in patients with cirrhosis and ascites (TransImmune): protocol for a randomised, double-blind, Phase IIa, placebo-controlled trial</news:title><news:keywords>Cirrhosis, microbiota</news:keywords></news:news></url><url><loc>https://2medical.news/2026/08/14/differential-prognostic-impact-of-potent-p2y%e2%82%81%e2%82%82-inhibitors-in-patients-with-acute-myocardial-infarction-by-bleeding-risk/</loc><news:news><news:publication><news:name>2 Medical News</news:name><news:language>en-gb</news:language></news:publication><news:publication_date>2026-08-14T07:00:34+00:00</news:publication_date><news:title>Differential Prognostic Impact of Potent P2Y₁₂ Inhibitors in Patients With Acute Myocardial Infarction by Bleeding Risk</news:title><news:keywords>AMI</news:keywords></news:news></url></urlset>
